Your browser is no longer supported. Please, upgrade your browser.
XLV Health Care Select Sector SPDR ETF daily Stock Chart
Health Care Select Sector SPDR ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-2.72%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month1.21%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter5.31%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-4.14%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-2.61%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range55.99 - 76.52 Perf YTD-3.44%
Dividend1.10 P/FCF- EPS past 5Y- ROI- 52W High-9.44% Beta-
Dividend %1.59% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low23.78% ATR0.86
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)44.74 Volatility1.13% 1.16%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.95 Prev Close69.97
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume12.25M Price69.30
Recom- SMA20-1.63% SMA501.01% SMA200-0.35% Volume11,792,600 Change-0.96%
May-04-16 11:59AM  Why Tobins Q Should Make You More Cautious Towards The Stock Market Today Yahoo Finance Contributors
09:08AM  Rationale for the St. Jude Medical-Abbott Merger Transaction Market Realist
06:45AM  Abbott Buys St. Jude Medical for $85 per Share in Cash and Stock Market Realist
May-03-16 11:29AM  No This Chart Doesnt Prove This Is The Most Hated Bull Market Yahoo Finance Contributors
07:00AM  Feds Dovish Stance What Does it Mean Yahoo Finance Contributors
May-02-16 05:40PM  Tech-Heavy QQQ ETF Halts Row Of Losses As Amazon Eyes $700 at Investor's Business Daily
04:16PM  The Last Week of April Wasnt Good for Biotechnology Stocks Market Realist
06:36AM  Technology and Healthcare SPDR Indices Fell Due to Weak Earnings Market Realist
Apr-30-16 01:01PM  The Fed Flies Like a Dove Yahoo Finance Contributors
11:06AM  LabCorps Growth Drivers in 1Q16: Organic Growth, Acquisitions Market Realist
11:01AM  Advance Estimates of U.S. GDP Growth Yahoo Finance Contributors
Apr-29-16 06:06PM  Understanding Regenerons Operating Expenses and Margins Market Realist
04:10PM  Apple Drives Selloff on April's Last Trading Day at TheStreet
12:28PM  Warren Buffett just laughed off Carl Icahn's dire predictions Yahoo Finance
Apr-28-16 10:53AM  Understanding Quest Diagnostics Valuation Multiple Compared to Those of Peers Market Realist
10:06AM  Tysabri Reports Strong Patient Growth in 1Q16 Market Realist
08:52AM  Cramer: Health care 'very interesting' CNBC
Apr-26-16 09:06PM  What Do Analysts Recommend for Abbott after 1Q16 Results? Market Realist
09:05PM  Large-Cap Update: Illuminas Stock Tanks on New Earnings Estimate Market Realist
08:00PM  Earnings Guide: 3 Insights to Consider in U.S. Markets (QCOM, V) at Investopedia
Apr-25-16 08:06PM  What Drove Abbotts Diagnostics Division Revenues? Market Realist
09:07AM  What Drove UnitedHealth Groups Medicare & Retirement Business in 1Q16? Market Realist
Apr-22-16 05:24PM  Medical Device Makers Keep Health Care Funds Off The Deathbed at Investor's Business Daily
11:07AM  What Will Drive Baxters 1Q16 Results? Market Realist
11:04AM  Cost-Cutting Drove Zimmer Biomets Earnings and Sustained Margins Market Realist
05:30AM  Health Care Sector Is Feeling Better at TheStreet
Apr-21-16 03:35PM  Health care breakout? CNBC
01:01PM  The Fed and the Dangers of the Dove Yahoo Finance Contributors
11:06AM  Thoratec Acquisition: The Impact on St. Judes Growth Potential Market Realist
Apr-19-16 07:36PM  Health Fund Shows Strength; Gold Sparkles But Silver Outshines
05:50PM  ETF Flows: Health Care ETFs Are Shedding Assets in 2016 (FXH, XLV) at Investopedia
04:02PM  2016 Investment Landscape: Right Sector at the Right Time
Apr-18-16 05:18PM  Recovery in Crude Prices Lifts Energy and Healthcare SPDR Indexes
03:55PM  St. Jude Medicals Market Position and Opportunities
03:54PM  St. Jude Medical: Stock Performance Compared to Peers
03:39PM  Adam Parker recommends biotech
02:03PM  The Simple Way I Search for the Next Hit Stock at Motley Fool
11:06AM  XLV Mid-Cap Stocks: Why Mallinckrodt Fell Due to Profit-Booking
Apr-13-16 01:26PM  Regeneron and Intellia Therapeutics Will Develop CRISPR/Cas
01:26PM  Analyzing XLV: Why Did It Remain Stable and Positive?
06:12AM  Companies setting the bar low
Apr-12-16 05:18PM  Rally in SPDR Indexes Backed by Optimism in Energy, Metal Sectors
01:53PM  Triple digit gains in Dow
12:34PM  Bet on inertia in health care: Pro
Apr-11-16 04:09PM  Wall Street Grows Gloomy as Alcoa Kicks Off Earnings Reports at TheStreet
03:14PM  Large-Cap News: Edwards Surged on SAPIENT 3 TAVR Data
10:38AM  Q1 Earnings Appear Dull: ETFs & Stocks to Bet On
09:34AM  Finance, Health Care Lag S&P Sector ETFs -- Check These Charts at TheStreet
06:27AM  Markets Track Rise in Crude as Dudley Expects Gradual Rate Hike
Apr-08-16 05:25PM  How Does Perrigo Compare to Its Peers in Valuation?
06:39AM  Intensive Care Required for Healthcare and Biotechnology Sectors
Apr-07-16 06:06PM  Merger Arbitrage Yielded 8% Return in 2015: Will It Work in 2016?
05:06PM  UBS: It's going to get worse...
02:21PM  What Does the Feds Cautious Move Mean for the Healthcare Sector?
02:12PM  2016 a lull for health care: Pro
09:30AM  The Zacks Analyst Blog Highlights: Allergan, Pfizer, Health Care Select Sector SPDR Fund, iShares U.S. Healthcare ETF and Vanguard Health Care ETF
09:08AM  XLVs Mid Caps Underperform SPY
Apr-06-16 06:50PM  Stock ETFs Rise Sharply On Falling Crude Stockpiles; Biotechs Surge
04:18PM  XLV Large Caps: Pfizer Moves Up on Inflectra Approval from FDA
04:16PM  Allergan Fell on the Possible Termination of Pfizer Merger
01:04AM  Understanding Acthars Big Contribution to Mallinckrodts Top-line
Apr-05-16 03:02PM  US Markets Fall despite Rising Non-Manufacturing PMI
02:50PM  Dont Buy The Greatest Fools Theory Of Investment Value
10:43AM  361 Capital Weekly Research Briefing: Nothing to see. Just another 8% bounce...
07:15AM  Pro's range-bound market call
Apr-02-16 03:06PM  Why You Should Exercise Caution When Investing in Healthcare
02:03PM  The Secrets Out: These Biotech Marvels Have Fallen Too Far
Apr-01-16 05:13PM  Positive Market Sentiment as Non-Farm Payroll Beats Expectations
09:08AM  Finding the Pulse of Thermo Fishers Life Technologies
07:40AM  Improving Investor Sentiments Drive Medtronics Stock Performance
07:00AM  Low-Cost Exposure to U.S. Healthcare Firms at Morningstar
Mar-31-16 02:01PM  Linking Health Care Discussions with Wealth Care Results
12:07PM  This Indicator Suggests A Bear Market Is Now Underway And Its Likely To Be A Painful One
09:54AM  Business Cycle Perspective: Has the Healthcare Sector Hit Bottom?
09:54AM  Yellens Caution Led Battered Healthcare Up 1.2% on March 29
09:39AM  SPDR Gold Trust up big at open: Pisani
07:53AM  This is how central banks will get out of this low-growth bind at MarketWatch
Mar-30-16 11:44AM  Inside Thermo Fishers Stock Performance and Expectations
03:51AM  2 Top Sectors As Stocks Hit New Highs
Mar-29-16 09:17AM  How investors should pick stocks to beat a go-nowhere market
Mar-25-16 03:06AM  Eli Lillys Taltz Receives FDA Approval: How Was LLY Affected?
03:05AM  How Innovation Is Driving JNJs Med Tech Segment Growth
02:48AM  XLV vs. VGHCX: ETF vs. Mutual Fund Case Study at Investopedia
Mar-23-16 03:14PM  Merck Wins over Gilead, Trading above 100-Day Moving Average
03:14PM  Is XLV Poised to Move towards Positive Year-To-Date Returns?
Mar-22-16 04:19PM  US Markets Rebound after Brussels Attack: Gold Trades Higher
Mar-21-16 05:07PM  Gold SPDRs Fall as US Fed Members Turn Hawkish in Rate Hikes
04:38PM  Could Repatha Be Amgens Key Growth Opportunity in 2016?
10:43AM  Companies havent fudged their numbers this much since the financial crisis
Mar-18-16 02:05PM  Who Were the Worst Performers in XLVs Mid-Cap Space?
02:04PM  Whats Really Driving Humanas Healthcare Services Segment?
12:00PM  Trading biotech, health care unknowns
08:30AM  McKesson to cut jobs, take charge as part of restructuring plan at MarketWatch
Mar-16-16 04:23PM  How Have XLVs Large-Caps Performed?
04:23PM  XLV Falls during a Tough Day for Biotechs
03:13PM  Health care fund faces bearish position
12:16PM  59% of fund managers see an economy in its final innings highest percent since 2008 at MarketWatch
Mar-15-16 11:05PM  Did the Acquisition Help Allergans International Brands Segment?
10:07PM  How Is Allergans US Medical Aesthetics Segment Doing?
09:10PM  Pfizer-Allergan: Will It Be the New Biopharmaceutical Leader?
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.